{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:44:07Z","timestamp":1744166647671},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1038\/s41440-019-0312-9","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T07:02:35Z","timestamp":1565679755000},"page":"1951-1960","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism"],"prefix":"10.1038","volume":"42","author":[{"given":"Kaoru","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasufumi","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiro","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"key":"312_CR1","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69:1811\u20131820. https:\/\/doi.org\/10.1016\/j.jacc.2017.01.052","journal-title":"J Am Coll Cardiol"},{"key":"312_CR2","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","volume":"83","author":"KT Weber","year":"1991","unstructured":"Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991;83:1849\u20131865.","journal-title":"Circulation"},{"key":"312_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.HYP.0000118519.66430.22","volume":"43","author":"A Nishiyama","year":"2004","unstructured":"Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, et al. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone\/salt-induced hypertensive rats. Hypertension. 2004;43:841\u2013848. https:\/\/doi.org\/10.1161\/01.HYP.0000118519.66430.22 .","journal-title":"Hypertension"},{"key":"312_CR4","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s41440-018-0093-6","volume":"41","author":"S Matsui","year":"2018","unstructured":"Matsui S, Kishimoto S, Kajikawa M, Hashimoto H, Kihara Y, Matsumoto T, et al. Microvascular endothelial function is impaired in patients with idiopathic hyperaldosteronism. Hypertens Res. 2018;41:932\u2013938. https:\/\/doi.org\/10.1038\/s41440-018-0093-6 .","journal-title":"Hypertens Res"},{"key":"312_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","volume":"62","author":"S Savard","year":"2013","unstructured":"Savard S, Amar L, Plouin P-F, Steichen O. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension. 2013;62:331\u2013336. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.01060 .","journal-title":"Hypertension"},{"key":"312_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41440-018-0126-1","volume":"42","author":"J Uraki","year":"2018","unstructured":"Uraki J, Onishi Y, Ito M, Taniguchi M, Ogura T, Fujimoto N, et al. Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study. Hypertens Res. 2018;42:40\u201351. https:\/\/doi.org\/10.1038\/s41440-018-0126-1 .","journal-title":"Hypertens Res"},{"key":"312_CR7","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/HYPERTENSIONAHA.117.10263","volume":"71","author":"Y Ohno","year":"2018","unstructured":"Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, et al. Prevalence of cardiovascular disease and its risk factors in primary aldosteronismnovelty and significance. Hypertension. 2018;71:530\u2013537. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10263 .","journal-title":"Hypertension"},{"key":"312_CR8","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1210\/jc.2008-2116","volume":"94","author":"E Born-Frontsberg","year":"2009","unstructured":"Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R, et al. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German conn\u2019s registry. J Clin Endocrinol Metab. 2009;94:1125\u20131130. https:\/\/doi.org\/10.1210\/jc.2008-2116 .","journal-title":"J Clin Endocrinol Metab"},{"key":"312_CR9","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","volume":"60","author":"M Reincke","year":"2012","unstructured":"Reincke M, Fischer E, Gerum S, Merkle K, Schulz S, Pallauf A, et al. Observational study mortality in treated primary aldosteronism: the German conn\u2019s registry. Hypertension. 2012;60:618\u2013624. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.197111 .","journal-title":"Hypertension"},{"key":"312_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1681\/ASN.2009030300","volume":"21","author":"G Nguyen","year":"2010","unstructured":"Nguyen G, Muller DN. The biology of the (pro)renin receptor. J Am Soc Nephrol. 2010;21:18\u201323. https:\/\/doi.org\/10.1681\/ASN.2009030300 .","journal-title":"J Am Soc Nephrol"},{"key":"312_CR11","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/FJC.0b013e3181f21576","volume":"56","author":"P Balakumar","year":"2010","unstructured":"Balakumar P, Jagadeesh G. Cardiovascular and renal pathologic implications of prorenin, renin, and the (Pro)renin receptor: promising young players from the old renin-angiotensin-aldosterone system. J Cardiovasc Pharm. 2010;56:570\u2013579.","journal-title":"J Cardiovasc Pharm"},{"issue":"5","key":"312_CR12","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1097\/HJH.0000000000000504","volume":"33","author":"Chiara Recarti","year":"2015","unstructured":"Recarti C, Seccia TM, Caroccia B, Gonzales-Campos A, Ceolotto G, Lenzini L, et al. Expression and functional role of the prorenin receptor in the human adrenocortical zona glomerulosa and in primary aldosteronism. J Hypertens. 2015;33. https:\/\/doi.org\/10.1097\/HJH.0000000000000504 .","journal-title":"Journal of Hypertension"},{"key":"312_CR13","doi-asserted-by":"publisher","first-page":"10939","DOI":"10.1074\/jbc.273.18.10939","volume":"273","author":"J Ludwig","year":"1998","unstructured":"Ludwig J, Kerscher S, Brandt U, Pfeiffer K, Getlawi F, Apps DK, et al. Identification and characterization of a novel 9.2-kDa membrane sector- associated protein of vacuolar proton-ATPase from chromaffin granules. J Biol Chem. 1998;273:10939\u201310947. https:\/\/doi.org\/10.1074\/jbc.273.18.10939 .","journal-title":"J Biol Chem"},{"key":"312_CR14","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/HYPERTENSIONAHA.108.127258","volume":"53","author":"C Cousin","year":"2009","unstructured":"Cousin C, Bracquart D, Contrepas A, Corvol P, Muller L, Nguyen G. Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma. Hypertension. 2009;53:1077\u20131082. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.108.127258 .","journal-title":"Hypertension"},{"key":"312_CR15","doi-asserted-by":"publisher","first-page":"e0158068","DOI":"10.1371\/journal.pone.0158068","volume":"11","author":"Y Amari","year":"2016","unstructured":"Amari Y, Morimoto S, Nakajima F, Ando T, Ichihara A. Serum soluble (pro)renin receptor levels in maintenance hemodialysis patients. PLoS ONE. 2016;11:e0158068. https:\/\/doi.org\/10.1371\/journal.pone.0158068 .","journal-title":"PLoS ONE"},{"key":"312_CR16","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/hr.2014.46","volume":"37","author":"S Morimoto","year":"2014","unstructured":"Morimoto S, Ando T, Niiyama M, Seki Y, Yoshida N, Watanabe D, et al. Serum soluble (pro)renin receptor levels in patients with essential hypertension. Hypertens Res. 2014;37:642\u2013648. https:\/\/doi.org\/10.1038\/hr.2014.46 .","journal-title":"Hypertens Res"},{"key":"312_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21767\/2472-5056.100053","volume":"03","author":"T Miyaoka","year":"2018","unstructured":"Miyaoka T, Morimoto S, Kataoka H, Mochizuki T, Tsuchiya K, Ichihara A, et al. Serum soluble (pro) renin receptor level is increased in association with impaired renal function in patients with autosomal dominant polycystic kidney disease. J Clin Exp Nephrol. 2018;03:1\u20136. https:\/\/doi.org\/10.21767\/2472-5056.100053 .","journal-title":"J Clin Exp Nephrol"},{"key":"312_CR18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","volume":"58","author":"T Nishikawa","year":"2011","unstructured":"Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, et al. Guidelines for the diagnosis and treatment of primary aldosteronism: The Japan Endocrine Society 2009. Endocr J. 2011;58:711\u2013721.","journal-title":"Endocr J"},{"key":"312_CR19","first-page":"1","volume":"1","author":"Y Kaneshiro","year":"2007","unstructured":"Kaneshiro Y, Ichihara A, Sakoda M, Kurauchi A, Takemitsu T, Itoh H. Cilnidipine and telmisartan similarly improves vascular damage in hypertensive patients. Clin Med Insights Cardiol. 2007;1:1\u201311.","journal-title":"Clin Med Insights Cardiol"},{"key":"312_CR20","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00270-016-1335-0","volume":"39","author":"S Morita","year":"2016","unstructured":"Morita S, Yamazaki H, Sonoyama Y, Nishina Y, Ichihara A, Sakai S. Successful adrenal venous sampling by non-experts with reference to CT images. Cardiovasc Interv Radio. 2016;39:1001\u20131006. https:\/\/doi.org\/10.1007\/s00270-016-1335-0 .","journal-title":"Cardiovasc Interv Radio"},{"key":"312_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5551\/jat.13.101","volume":"13","author":"K Shirai","year":"2006","unstructured":"Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb. 2006;13:101\u2013107. https:\/\/doi.org\/10.5551\/jat.13.101 .","journal-title":"J Atheroscler Thromb"},{"key":"312_CR22","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1161\/CIRCULATIONAHA.106.649939","volume":"115","author":"MS Sabatine","year":"2007","unstructured":"Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, et al. Prognostic significance of the Centers for Disease Control\/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation. 2007;115:1528\u20131536. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.649939 .","journal-title":"Circulation"},{"key":"312_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/ki.1975.120","volume":"8","author":"P Weidmann","year":"1975","unstructured":"Weidmann P, De Myttenaere Bursztein S, Maxwell MH, De Lima J. Effect of aging on plasma renin and aldosterone in normal man. Kidney Int. 1975;8:325\u2013333. https:\/\/doi.org\/10.1038\/ki.1975.120 .","journal-title":"Kidney Int"},{"key":"312_CR24","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1161\/01.RES.0000251700.00994.0d","volume":"99","author":"JH Schefe","year":"2006","unstructured":"Schefe JH, Menk M, Reinemund J, Effertz K, Hobbs RM, Pandolfi PP, et al. A novel signal transduction cascade involving direct physical interaction of the renin\/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res. 2006;99:1355\u20131366. https:\/\/doi.org\/10.1161\/01.RES.0000251700.00994.0d .","journal-title":"Circ Res"},{"key":"312_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.peptides.2013.08.022","volume":"49","author":"H Yamamoto","year":"2013","unstructured":"Yamamoto H, Kaneko K, Ohba K, Morimoto R, Hirose T, Satoh F, et al. Increased expression of (pro)renin receptor in aldosterone-producing adenomas. Peptides. 2013;49:68\u201373. https:\/\/doi.org\/10.1016\/j.peptides.2013.08.022 .","journal-title":"Peptides"},{"key":"312_CR26","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1210\/jc.2013-2805","volume":"98","author":"P Mulatero","year":"2013","unstructured":"Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A, et al. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab. 2013;98:4826\u201333. https:\/\/doi.org\/10.1210\/jc.2013-2805 .","journal-title":"J Clin Endocrinol Metab"},{"key":"312_CR27","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1097\/HJH.0b013e32831286fd","volume":"26","author":"G Bernini","year":"2008","unstructured":"Bernini G, Galetta F, Franzoni F, Bardini M, Taurino C, Bernardini M, et al. Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism. J Hypertens. 2008;26:2399\u20132405. https:\/\/doi.org\/10.1097\/HJH.0b013e32831286fd .","journal-title":"J Hypertens"},{"key":"312_CR28","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1172\/JCI117269","volume":"93","author":"M Young","year":"1994","unstructured":"Young M, Fullerton M, Dilley R, Funder J. Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest. 1994;93:2578\u201383. https:\/\/doi.org\/10.1172\/JCI117269 .","journal-title":"J Clin Invest"},{"key":"312_CR29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","volume":"51","author":"NJ Brown","year":"2008","unstructured":"Brown NJ. Aldosterone and vascular inflammation. Hypertension. 2008;51:161\u2013167.","journal-title":"Hypertension"},{"key":"312_CR30","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1006\/jmcc.2000.1129","volume":"32","author":"P Lijnen","year":"2000","unstructured":"Lijnen P, Petrov V. Induction of cardiac fibrosis by aldosterone. J Mol Cell Cardiol. 2000;32:865\u2013879.","journal-title":"J Mol Cell Cardiol"},{"key":"312_CR31","doi-asserted-by":"publisher","first-page":"H2372","DOI":"10.1152\/ajpheart.00283.2011","volume":"301","author":"N L\u00f3pez-Andr\u00e9s","year":"2011","unstructured":"L\u00f3pez-Andr\u00e9s N, Martin-Fernandez B, Rossignol P, Zannad F, Lahera V, Fortuno MA, et al. A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone. Am J Physiol Heart Circ Physiol. 2011;301:H2372\u2013H2382. https:\/\/doi.org\/10.1152\/ajpheart.00283.2011 .","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"312_CR32","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/hr.2017.68","volume":"40","author":"K Shiina","year":"2017","unstructured":"Shiina K, Tomiyama H. New approach to arterial stiffness: BP-independent local carotid stiffness. Hypertens Res. 2017;40:910\u2013911. https:\/\/doi.org\/10.1038\/hr.2017.68 .","journal-title":"Hypertens Res"},{"key":"312_CR33","doi-asserted-by":"publisher","first-page":"B4","DOI":"10.1093\/eurheartj\/suw058","volume":"19","author":"R Asmar","year":"2017","unstructured":"Asmar R. Principles and usefulness of the cardio-ankle vascular index (CAVI): a new global arterial stiffness index. Eur Hear J, Suppl. 2017;19:B4\u2013B10. https:\/\/doi.org\/10.1093\/eurheartj\/suw058 .","journal-title":"Eur Hear J, Suppl"},{"key":"312_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R. Inflammation or atherogenesis. N Engl J Med. 1999;340:115\u2013126. https:\/\/doi.org\/10.1056\/NEJM199901143400207 .","journal-title":"N Engl J Med"},{"key":"312_CR35","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1210\/jc.2011-0354","volume":"96","author":"E Pimenta","year":"2011","unstructured":"Pimenta E, Gordon RD, Ahmed AH, Cowley D, Leano R, Marwick TH, et al. Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study. J Clin Endocrinol Metab. 2011;96:2813\u20132820. https:\/\/doi.org\/10.1210\/jc.2011-0354 .","journal-title":"J Clin Endocrinol Metab"},{"key":"312_CR36","doi-asserted-by":"publisher","first-page":"F130","DOI":"10.1152\/ajprenal.00275.2011","volume":"303","author":"Y Huang","year":"2012","unstructured":"Huang Y, Yamamoto T, Misaki T, Suzuki H, Togawa A, Ohashi N, et al. Enhanced intrarenal receptor-mediated prorenin activation in chronic progressive anti-thymocyte serum nephritis rats on high salt intake. AJP Ren Physiol. 2012;303:F130\u2013F138. https:\/\/doi.org\/10.1152\/ajprenal.00275.2011 .","journal-title":"AJP Ren Physiol"},{"key":"312_CR37","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, et al. Renal damage in primary aldosteronism: results of the PAPY study. Hypertension. 2006;48:232\u2013238. https:\/\/doi.org\/10.1161\/01.HYP.0000230444.01215.6a .","journal-title":"Hypertension"},{"issue":"4","key":"312_CR38","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41440-018-0201-7","volume":"42","author":"Mitsuhiro Nishimoto","year":"2019","unstructured":"Kawarazaki W, Kawakami-Mori F, Oba S, Isshiki M, Ohtsu H, Shibata S, et al. Mineralocorticoid receptor blockade suppresses dietary salt-induced ACEI\/ARB-resistant albuminuria in non-diabetic hypertension: a sub-analysis of evaluate study. Hypertens Res. 2019. https:\/\/doi.org\/10.1038\/s41440-018-0201-7 .","journal-title":"Hypertension Research"},{"key":"312_CR39","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1097\/01.ASN.0000083982.74108.54","volume":"14","author":"S Arima","year":"2003","unstructured":"Arima S, Kohagura K, Xu HL, Sugawara A, Abe T, Satoh F, et al. Nongenomic vascular action of aldosterone in the glomerular microcirculation. J Am Soc Nephrol. 2003;14:2255\u20132263. https:\/\/doi.org\/10.1097\/01.ASN.0000083982.74108.54 .","journal-title":"J Am Soc Nephrol"},{"key":"312_CR40","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1161\/01.RES.0000106135.02935.E1","volume":"93","author":"TR Uhrenholt","year":"2003","unstructured":"Uhrenholt TR, Schjerning J, Hansen PB, Norregaard R, Jensen BL, Sorensen GL. et al. Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone. Circ Res. 2003;93:1258\u20131266. https:\/\/doi.org\/10.1161\/01.RES.0000106135.02935.E1 .","journal-title":"Circ Res"},{"key":"312_CR41","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.semnephrol.2007.07.005","volume":"27","author":"A Ichihara","year":"2007","unstructured":"Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Itoh H. The (pro)renin receptor and the kidney. Semin Nephrol. 2007;27:524\u2013528. https:\/\/doi.org\/10.1016\/j.semnephrol.2007.07.005 .","journal-title":"Semin Nephrol"},{"key":"312_CR42","doi-asserted-by":"publisher","unstructured":"Narumi K, Sato E, Hirose T, Yamamoto T, Nakamichi T, Miyazaki M, et al. (Pro)renin receptor is involved in mesangial fibrosis and matrix expansion. Sci Rep. 2018;8. https:\/\/doi.org\/10.1038\/s41598-017-18314-w .","DOI":"10.1038\/s41598-017-18314-w"},{"key":"312_CR43","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1681\/ASN.V11101882","volume":"11","author":"SJ Pinto-Sietsma","year":"2000","unstructured":"Pinto-Sietsma SJ, Janssen WM, Hillege HL, Navis G, De Zeeuw D, De Jong PE. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol. 2000;11:1882\u20131888.","journal-title":"J Am Soc Nephrol"},{"key":"312_CR44","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1172\/JCI200214276.Introduction","volume":"109","author":"G Nguyen","year":"2002","unstructured":"Nguyen G, Delarue F, Burckl\u00e9 C, Bouzhir L, Giller T, Sraer J. Pivotal role of the renin\/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002;109:1417\u20131427. https:\/\/doi.org\/10.1172\/JCI200214276.Introduction .","journal-title":"J Clin Invest"},{"key":"312_CR45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/1440-1681.12376","volume":"42","author":"T Zhu","year":"2015","unstructured":"Zhu T, Miller AG, Deliyanti D, Berka DR, Agrotis A, Campbell DJ, et al. Prorenin stimulates a pro-angiogenic and pro-inflammatory response in retinal endothelial cells and an M1 phenotype in retinal microglia. Clin Exp Pharm Physiol. 2015;42:537\u2013548. https:\/\/doi.org\/10.1111\/1440-1681.12376 .","journal-title":"Clin Exp Pharm Physiol"},{"key":"312_CR46","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/hr.2010.284","volume":"34","author":"A Yoshikawa","year":"2011","unstructured":"Yoshikawa A, Aizaki Y, Kusano KI, Kishi F, Susumu T, Iida S, et al. The (pro)renin receptor is cleaved by ADAM19 in the Golgi leading to its secretion into extracellular space. Hypertens Res. 2011;34:599\u2013605. https:\/\/doi.org\/10.1038\/hr.2010.284 .","journal-title":"Hypertens Res"},{"key":"312_CR47","doi-asserted-by":"publisher","first-page":"E1898","DOI":"10.1073\/pnas.1602397113","volume":"113","author":"X Lu","year":"2016","unstructured":"Lu X, Wang F, Xu C, Soodvilai S, Peng K, Su J, et al. Soluble (pro)renin receptor via \u03b2-catenin enhances urine concentration capability as a target of liver X receptor. Proc Natl Acad Sci USA. 2016;113:E1898\u2013E1906. https:\/\/doi.org\/10.1073\/pnas.1602397113 .","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0312-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0312-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0312-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:21:14Z","timestamp":1684617674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-019-0312-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["312"],"URL":"https:\/\/doi.org\/10.1038\/s41440-019-0312-9","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]},"assertion":[{"value":"22 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}